Alzheimer’s Care Innovation: Advancing Implementation Across Europe
Pioneering Alzheimer's Care Innovation in Europe
Alzheimer's care innovation is transforming Europe's approach to the disease, shifting from policy discussions to real-world implementation of disease-modifying therapies. With 10 milli...
Long-Term Benefits of Composite Treatment Targets in Type 2 Diabetes Management
Sustained Composite Treatment Targets Enhance Clinical and Economic Outcomes in Type 2 Diabetes
A recent modeling study examines the long-term benefits of achieving
Navigating Economic Resilience Through Life Sciences Investment
Navigating a Leaderless Global Economy Through Life Sciences Investment
In an era of deepening geopolitical fragmentation, often termed the G-Zero world, global governments are urged to prioritize bold life sci...
EU Medicine Authorizations 2025: A Milestone for Innovation and Accessibility
EU Medicine Authorizations 2025: A Year of Innovation
Advancements in EU Medicine Authorizations for 2025
In 2025, the European Medicines Agency (EMA) recommended 104 medicines for marketing authorisati...
FDA Updates Labeling on Febrile Seizure Risks in Influenza Vaccine for Children
FDA Labeling Mandate on Febrile Seizure Risks
In a significant update to vaccine safety protocols, the U.S. Food and Drug Administration (FDA) has required pediatric influenza vaccines to include warnings about an elevated risk of febri...
Guiding Principles for Ethical AI Integration in Drug Development
Guiding Principles for Ethical AI Integration in Drug Lifecycle
The EMA/FDA document provides a foundational framework for ethical AI integration into drug development, emphasizing its potential to transform evidence g...
